1. Home
  2. RPID vs BTMD Comparison

RPID vs BTMD Comparison

Compare RPID & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPID
  • BTMD
  • Stock Information
  • Founded
  • RPID 2006
  • BTMD 2012
  • Country
  • RPID United States
  • BTMD United States
  • Employees
  • RPID N/A
  • BTMD N/A
  • Industry
  • RPID Medical Specialities
  • BTMD Medicinal Chemicals and Botanical Products
  • Sector
  • RPID Health Care
  • BTMD Health Care
  • Exchange
  • RPID Nasdaq
  • BTMD Nasdaq
  • Market Cap
  • RPID 138.9M
  • BTMD 127.8M
  • IPO Year
  • RPID 2021
  • BTMD N/A
  • Fundamental
  • Price
  • RPID $3.71
  • BTMD $4.34
  • Analyst Decision
  • RPID Strong Buy
  • BTMD Strong Buy
  • Analyst Count
  • RPID 2
  • BTMD 1
  • Target Price
  • RPID $8.00
  • BTMD $8.00
  • AVG Volume (30 Days)
  • RPID 91.6K
  • BTMD 82.4K
  • Earning Date
  • RPID 08-08-2025
  • BTMD 08-06-2025
  • Dividend Yield
  • RPID N/A
  • BTMD N/A
  • EPS Growth
  • RPID N/A
  • BTMD 201.68
  • EPS
  • RPID N/A
  • BTMD 0.60
  • Revenue
  • RPID $29,645,000.00
  • BTMD $199,379,000.00
  • Revenue This Year
  • RPID $18.54
  • BTMD $5.87
  • Revenue Next Year
  • RPID $20.55
  • BTMD $8.59
  • P/E Ratio
  • RPID N/A
  • BTMD $7.58
  • Revenue Growth
  • RPID 28.36
  • BTMD 6.44
  • 52 Week Low
  • RPID $0.66
  • BTMD $3.04
  • 52 Week High
  • RPID $4.50
  • BTMD $8.03
  • Technical
  • Relative Strength Index (RSI)
  • RPID 54.24
  • BTMD 56.64
  • Support Level
  • RPID $3.65
  • BTMD $3.98
  • Resistance Level
  • RPID $4.50
  • BTMD $4.75
  • Average True Range (ATR)
  • RPID 0.30
  • BTMD 0.21
  • MACD
  • RPID 0.03
  • BTMD 0.03
  • Stochastic Oscillator
  • RPID 47.45
  • BTMD 50.60

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Share on Social Networks: